BAP1, functioning as a chromatin regulator, has been found to regulate the expression of lncRNA NEAT-1, impacting gemcitabine sensitivity in CCA cells through epigenetic mechanisms. The gene discussed is NEAT1; the disease is cholangiocarcinoma.